Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 3
2008 1
2011 2
2013 12
2014 12
2015 2
2016 1
2018 2
2019 3
2020 4
2021 2
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sfgmtc[Corporate Author] (1 results)?
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).
Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, Turlure P, Reimer P, Wagner-Drouet E, Sanhes L, Houot R, Roussel M, Kroschinsky F, Dreger P, Viardot A, de Leval L, Rosenwald A, Gaulard P, Wulf G, Villate A, Latiere C, Elmaagacli A, Glass B, Poeschel V, Damaj G, Sibon D, Durot E, Bilger K, Banos A, Haenel M, Dreyling M, Keller U, Tiab M, Drenou B, Cornillon J, Nguyen S, Robin M, Nickelsen M, Trümper L, Lenz G, Ziepert M, Schmitz N; French Lymphoma Study Association (LYSA), the Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), and the German Lymphoma Alliance (GLA). Tournilhac O, et al. J Clin Oncol. 2024 Nov 10;42(32):3788-3794. doi: 10.1200/JCO.24.00554. Epub 2024 Sep 13. J Clin Oncol. 2024. PMID: 39270145 Clinical Trial.
HLA haplotype frequencies and diversity in patients with hemoglobinopathies.
Scigliuolo GM, Boukouaci W, Cappelli B, Volt F, Rivera Franco MM, Dhédin N, de Latour RP, Devalck C, Dalle JH, Castelle M, Hermine O, Chardin MO, Poiré X, Brichard B, Paillard C, Rafii H, Kenzey C, Wu CL, Bouassida J, Robin M, Raus N, Rocha V, Ruggeri A, Gluckman E, Tamouza R; Eurocord and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC). Scigliuolo GM, et al. EJHaem. 2023 Aug 4;4(4):963-969. doi: 10.1002/jha2.763. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024588 Free PMC article.
Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TC.
De Vos J, Birebent B, Faucher C, Giet O, Hicheri Y, Lemarie C, Baudoux E, Boulanger F, Garnier F, Larghero J, Pouthier F, Thibert JB, Yakoub-Agha I; SFGM-TC. De Vos J, et al. Pathol Biol (Paris). 2014 Aug;62(4):218-20. doi: 10.1016/j.patbio.2014.05.005. Epub 2014 Jul 1. Pathol Biol (Paris). 2014. PMID: 24996845 Free article.
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Philippe Walter L, Couronné L, Jais JP, Nguyen PD, Blaise D, Pigneux A, Socié G, Thieblemont C, Bachy E, Fegueux N, Chevallier P, Mohty M, Yakoub-Agha I, Peffault de Latour R, Jaccard A, Hermine O; Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Philippe Walter L, et al. Am J Hematol. 2021 Jul 1;96(7):834-845. doi: 10.1002/ajh.26200. Epub 2021 May 3. Am J Hematol. 2021. PMID: 33864708 Free article.
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
Longval T, Leprêtre AC, Ravinet A, Fayard A, Forcade E, Coman T, Redjoul R, Berceanu A, Buchbinder N, Berlie G, Mappoura M, Giannotti F, Chevillon F, Robin M, Peffault de Latour R, Sicre de Fontbrune F; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Longval T, et al. Bone Marrow Transplant. 2024 Jun;59(6):893-895. doi: 10.1038/s41409-024-02202-9. Epub 2024 Mar 9. Bone Marrow Transplant. 2024. PMID: 38461290 No abstract available.
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
Le Calvez B, Jullien M, Dalle JH, Renard C, Jubert C, Sterin A, Paillard C, Huynh A, Guenounou S, Bruno B, Gandemer V, Buchbinder N, Simon P, Pochon C, Sirvent A, Plantaz D, Kanold J, Béné MC, Rialland F, Grain A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC). Le Calvez B, et al. Hemasphere. 2024 Jul 8;8(7):e120. doi: 10.1002/hem3.120. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38978638 Free PMC article.
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study.
Bossard JB, Beuscart JB, Robin M, Mohty M, Barraco F, Chevallier P, Marchand T, Rubio MT, Charbonnier A, Blaise D, Bay JO, Botella-Garcia C, Damaj G, Beckerich F, Ceballos P, Cluzeau T, Cornillon J, Meunier M, Orvain C, Duhamel A, Garnier F, Kiladjian JJ, Yakoub-Agha I; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), the France-Intergroupe des Syndromes Myéloprolifératifs (FIM) and the Agence de la BioMédecine (ABM). Bossard JB, et al. Am J Hematol. 2021 Jan;96(1):80-88. doi: 10.1002/ajh.26034. Epub 2020 Nov 18. Am J Hematol. 2021. PMID: 33108024 Free article. Clinical Trial.
45 results